chr14-49633783-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_018139.3(DNAAF2):​c.1367C>T​(p.Pro456Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00131 in 1,593,556 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0074 ( 13 hom., cov: 33)
Exomes 𝑓: 0.00067 ( 19 hom. )

Consequence

DNAAF2
NM_018139.3 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.335

Publications

2 publications found
Variant links:
Genes affected
DNAAF2 (HGNC:20188): (dynein axonemal assembly factor 2) This gene encodes a highly conserved protein involved in the preassembly of dynein arm complexes which power cilia. These complexes are found in some cilia and are assembled in the cytoplasm prior to transport for cilia formation. Mutations in this gene have been associated with primary ciliary dyskinesia. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
DNAAF2 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 10
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029436946).
BP6
Variant 14-49633783-G-A is Benign according to our data. Variant chr14-49633783-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261012.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00735 (1120/152360) while in subpopulation AFR AF = 0.0255 (1062/41588). AF 95% confidence interval is 0.0243. There are 13 homozygotes in GnomAd4. There are 513 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018139.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF2
NM_018139.3
MANE Select
c.1367C>Tp.Pro456Leu
missense
Exon 1 of 3NP_060609.2
DNAAF2
NM_001378453.1
c.-505C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 2NP_001365382.1
DNAAF2
NM_001083908.2
c.1367C>Tp.Pro456Leu
missense
Exon 1 of 2NP_001077377.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF2
ENST00000298292.13
TSL:1 MANE Select
c.1367C>Tp.Pro456Leu
missense
Exon 1 of 3ENSP00000298292.8
DNAAF2
ENST00000406043.3
TSL:1
c.1367C>Tp.Pro456Leu
missense
Exon 1 of 2ENSP00000384862.3

Frequencies

GnomAD3 genomes
AF:
0.00734
AC:
1118
AN:
152242
Hom.:
13
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0256
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00281
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00182
AC:
411
AN:
225490
AF XY:
0.00140
show subpopulations
Gnomad AFR exome
AF:
0.0252
Gnomad AMR exome
AF:
0.00132
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000669
Gnomad OTH exome
AF:
0.000890
GnomAD4 exome
AF:
0.000668
AC:
962
AN:
1441196
Hom.:
19
Cov.:
92
AF XY:
0.000586
AC XY:
420
AN XY:
716784
show subpopulations
African (AFR)
AF:
0.0221
AC:
734
AN:
33250
American (AMR)
AF:
0.00152
AC:
66
AN:
43280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25658
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39514
South Asian (SAS)
AF:
0.0000469
AC:
4
AN:
85216
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40814
Middle Eastern (MID)
AF:
0.000698
AC:
4
AN:
5728
European-Non Finnish (NFE)
AF:
0.0000442
AC:
49
AN:
1107832
Other (OTH)
AF:
0.00175
AC:
105
AN:
59904
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
66
131
197
262
328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00735
AC:
1120
AN:
152360
Hom.:
13
Cov.:
33
AF XY:
0.00688
AC XY:
513
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.0255
AC:
1062
AN:
41588
American (AMR)
AF:
0.00281
AC:
43
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68020
Other (OTH)
AF:
0.00425
AC:
9
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
57
114
170
227
284
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00251
Hom.:
4
Bravo
AF:
0.00871
ESP6500AA
AF:
0.0190
AC:
81
ESP6500EA
AF:
0.000118
AC:
1
ExAC
AF:
0.00215
AC:
260
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 28, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

not provided Benign:2
May 28, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria.

Aug 28, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia 10 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
7.9
DANN
Benign
0.86
DEOGEN2
Benign
0.0063
T
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.78
FATHMM_MKL
Benign
0.043
N
LIST_S2
Benign
0.45
T
MetaRNN
Benign
0.0029
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L
PhyloP100
0.34
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.064
Sift
Benign
0.037
D
Sift4G
Uncertain
0.024
D
Polyphen
0.27
B
Vest4
0.079
MVP
0.32
MPC
0.54
ClinPred
0.021
T
GERP RS
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.040
gMVP
0.29
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137991407; hg19: chr14-50100501; COSMIC: COSV107319235; COSMIC: COSV107319235; API